Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 1

Status

Completed 18Recruiting 10Unknown 6Active not recruiting 5Terminated 3Withdrawn 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 438Carboplatin 321Nivolumab 293Cyclophosphamide 285Specimen Handling 257Paclitaxel 249Magnetic Resonance Spectroscopy 249Cisplatin 248Radiotherapy 218Dexamethasone 183Gemcitabine 177Biopsy 177durvalumab 169atezolizumab 149Doxorubicin 140Rituximab 138Lenalidomide 135Docetaxel 131Ipilimumab 130Bevacizumab 128Radiation 121Capecitabine 117Etoposide 116Oxaliplatin 114Fluorouracil 110Pemetrexed 109Radiosurgery 108fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Restraint, Physical × Clear all
NCT00002540 2026-04-28

Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
76,685 enrolled 23 charts
Genitourinary

Prostatic Neoplasms

NCT04888988 2026-04-24

CIPN

University of Rochester

Phase NA Active not recruiting
133 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04062552 2026-01-13

Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers

University of Rochester

Phase NA Active not recruiting
208 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05053191 2025-09-19

Advancing Nursing Practices in Hospital Oncology Care

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
84 enrolled
Gastrointestinal

Gastrointestinal Diseases, Gastrointestinal Neoplasms

NCT02750358 2025-06-22

Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
50 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡